Business ❯Finance ❯Corporate Actions
Corporate Actions Stock Market Market Analysis Investment Market Trends Investment Strategies Corporate Finance Financial Performance Investing Companies
The pharmaceutical giant reported an 8% revenue increase but a 19% profit decline, with softer FY26 growth guidance and plans for $100 million in specialty investments.